Viewing Study NCT01158105


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-04-11 @ 5:30 PM
Study NCT ID: NCT01158105
Status: UNKNOWN
Last Update Posted: 2016-01-18
First Post: 2010-07-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)
Sponsor: Baylor Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module